Search Results 991-1000 of 16862 for melatonin receptor agonists

1. Endocrinology - Doctors - Mayo Clinic

   Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...

2. A Study to Identify and Characterize Neurophysiological Biomarkers for Progression of Neurodegenerative Disease - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

3. Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic Cholangiocarcinoma - Mayo Clinic

   About this study. The purpose of this study is to assess the safety and preliminary efficacy of segmental ablative radioembolization in combination with ...

4. An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD - Mayo Clinic

   The purpose of this study is to evaluate the efficacy and safety of 2 daratumumab treatment regimens in participants with multiple myeloma who have received at ...

5. Endocrinology - Doctors - Mayo Clinic

   Endocrinology at Mayo Clinic offers treatment and specialty care for people with a wide range of rare and common endocrine disorders.

6. Mapping Patient-Centered Decision-Making In Metastatic Cancer Care Delivery In Florida - Mayo Clinic

   Participation eligibility · Female patients who received a clinical diagnosis of mBC that is either triple negative (TNBC) (estrogen receptor, progesterone ...

7. Phase 2 Study of Ipilimumab in Children and Adolescents (12 to < 18 Years) With Previously Treated or Untreated, Unresectable Stage III or Stage lV Malignant Melanoma - Mayo Clinic

   ... agonists; Symptomatic brain metastases; History of autoimmune diseases. Participating Mayo Clinic locations. Study statuses change often. Please contact the ...

8. Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer - Mayo Clinic

   ... agonists/antagonists and antiandrogens) within 1 year prior to randomization, unless it was in the neoadjuvant and/or adjuvant setting; agents such as 5 ...

9. Endocrinology - Doctors - Mayo Clinic

   Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota.

10. Neurology - Clinical trials

    ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...